adenosine A2A receptor antagonists (Advinus Therapeutics)

N/A

Report date: 2025/01/26 18:56:20
NME

Base Information

Drug Nameadenosine A2A receptor antagonists (Advinus Therapeutics)
Drug Alias NameAdenosine A2a receptor antagonist (Eurofins Advinus)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor antagonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsDepressionParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEurofins Advinus Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEurofins Advinus Ltd
Inactive CompaniesN/A
Active IndicationsDepression
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A